AbCellera Biologics Inc. ABCL Increase Decrease In Deferred Grant Income
Increase Decrease In Deferred Grant Income at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept abcl:IncreaseDecreaseInDeferredGrantIncome.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s increase decrease in deferred grant income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s increase decrease in deferred grant income?
- AbCellera Biologics Inc. (ABCL) reported increase decrease in deferred grant income of $2.36M in Q1 2026.
- How has AbCellera Biologics Inc.'s increase decrease in deferred grant income changed year-over-year?
- AbCellera Biologics Inc.'s increase decrease in deferred grant income increased by 93.1% year-over-year, from $1.22M to $2.36M.
- What is the long-term trend for AbCellera Biologics Inc.'s increase decrease in deferred grant income?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s increase decrease in deferred grant income has grown at a -41.3% compound annual growth rate (CAGR), from -$30.72M to $3.64M.
- What does increase decrease in deferred grant income mean?
- This represents the change in grant funding received in advance of the related research and development activities being performed. An increase indicates that the company has secured funding for future projects that has not yet been recognized as revenue. It serves as a leading indicator of future research activity and government or partner support.